Wednesday, February 6, 2019

Top 10 Blue Chip Stocks To Own For 2019

tags:TRIB,TNAV,TEL,OII,HDS,IPWR,NLST,XON,HSON,DVAX,

April 24, 2018: Markets opened higher again Tuesday but soon sank to losses and just kept falling throughout the trading session. The yield on 10-year Treasury bonds finally topped 3% early this morning and combined with lackluster earnings and cautious guidance from some blue chippers, stocks never had a chance to fly higher. Home prices rose sharply again and sales of new homes also posted a solid gain.

WTI crude oil for June delivery settled at $67.70 a barrel, down 1.4% for the day. June gold added about 0.7% on the day to settle at $1,333.00. Equities were headed for a lower close about 10 minutes before the bell as the Dow traded down 2.03% for the day, the S&P 500 traded down 1.66%, and the Nasdaq Composite traded down 2.04%.

Bitcoin futures (XBTK8) for May delivery traded at $9,410, up about 6% on the CBOE after opening at $8,970 this morning. The digital currency’s trading range for the day was $8,940 to $9,450.

The Dow stock posting the largest daily percentage loss ahead of the close Tuesday was 3M Company (NYSE: MMM) which traded down 6.99% at $200.78. The stock’s 52-week range is $192.36 to $259.77. Volume was about four times the daily average of around 2.7 million shares. The company reported so-so results this morning and lowered earnings guidance.

Top 10 Blue Chip Stocks To Own For 2019: Trinity Biotech plc(TRIB)

Advisors' Opinion:
  • [By Ethan Ryder]

    Trinity Biotech (NASDAQ: TRIB) and Neogen (NASDAQ:NEOG) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings and analyst recommendations.

  • [By Max Byerly]

    Trinity Biotech (NASDAQ: TRIB) is one of 25 publicly-traded companies in the “Diagnostic substances” industry, but how does it weigh in compared to its peers? We will compare Trinity Biotech to related businesses based on the strength of its analyst recommendations, valuation, risk, earnings, dividends, profitability and institutional ownership.

Top 10 Blue Chip Stocks To Own For 2019: TeleNav Inc.(TNAV)

Advisors' Opinion:
  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Telenav (TNAV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    ValuEngine upgraded shares of Telenav (NASDAQ:TNAV) from a sell rating to a hold rating in a research note published on Saturday.

    Several other equities research analysts also recently issued reports on TNAV. BidaskClub upgraded Telenav from a sell rating to a hold rating in a report on Friday. Zacks Investment Research upgraded Telenav from a sell rating to a hold rating in a report on Thursday, April 5th. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock presently has an average rating of Buy and an average target price of $11.17.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Telenav (TNAV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Blue Chip Stocks To Own For 2019: TE Connectivity Ltd.(TEL)

Advisors' Opinion:
  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on TE Connectivity (TEL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    United Capital Financial Advisers LLC boosted its position in TE Connectivity Ltd (NYSE:TEL) by 18.5% during the 1st quarter, HoldingsChannel reports. The fund owned 11,098 shares of the electronics maker’s stock after acquiring an additional 1,736 shares during the quarter. United Capital Financial Advisers LLC’s holdings in TE Connectivity were worth $1,109,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    TE Connectivity Ltd (NYSE:TEL) has been given a consensus recommendation of “Buy” by the fourteen research firms that are covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and nine have issued a buy recommendation on the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $114.30.

  • [By Joseph Griffin]

    Telcoin (CURRENCY:TEL) traded down 5.5% against the dollar during the 24-hour period ending at 14:00 PM ET on September 2nd. Over the last seven days, Telcoin has traded 20.9% higher against the dollar. Telcoin has a market capitalization of $25.25 million and $119,035.00 worth of Telcoin was traded on exchanges in the last day. One Telcoin token can now be purchased for $0.0008 or 0.00000011 BTC on popular exchanges including Kucoin, HitBTC, EtherDelta (ForkDelta) and IDEX.

  • [By Max Byerly]

    Allianz Asset Management GmbH raised its stake in TE Connectivity Ltd (NYSE:TEL) by 16.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,613,642 shares of the electronics maker’s stock after buying an additional 225,677 shares during the period. Allianz Asset Management GmbH owned about 0.46% of TE Connectivity worth $161,202,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Max Byerly]

    Achmea Investment Management B.V. increased its stake in TE Connectivity Ltd (NYSE:TEL) by 2.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 235,540 shares of the electronics maker’s stock after purchasing an additional 6,726 shares during the quarter. Achmea Investment Management B.V. owned approximately 0.07% of TE Connectivity worth $18,665,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Blue Chip Stocks To Own For 2019: Oceaneering International, Inc.(OII)

Advisors' Opinion:
  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Oceaneering International (OII)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell]

    I've written previously about my belief that shrinking oil inventories and rising crude oil prices will spark a recovery in energy services stocks, and I've already explained why Core Labs and Hess Corp are favorite stocks of mine to buy. Now, after reviewing Oceaneering International's (NYSE:OII) first-quarter results, I'm increasingly convinced that it's a great time to add this stock to any portfolio.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Oceaneering International (OII)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Benzinga News Desk]

    Shari Redstone is one “disloyal” media heiress, according to CBS (NYSE: CBS): Link

    ECONOMIC DATA US Initial Jobless Claims for May 18 234.0K vs 220.0K Est; Prior 222.0K. US Continuing Claims for May 11 1.74M vs 1.75M Est; Prior 1.71M Existing home sales report for April will be released at 10:00 a.m. ET. The Energy Information Administration’s weekly report on natural gas stocks in underground storage is schedule for release at 10:30 a.m. ET. Atlanta Fed President Raphael Bostic will speak at 10:35 a.m. ET. The Treasury is set to auction 7-year notes at 1:00 p.m. ET. The Kansas City Fed manufacturing index for May will be released at 11:00 a.m. ET. Philadelphia Federal Reserve Bank President Patrick Harker is set to speak at 2:00 p.m. ET. Data on money supply for the latest week will be released at 4:30 p.m. ET. ANALYST RATINGS UBS upgrades Deere (NYSE: DE) from Neutral to Buy Wells Fargo upgrades Oceaneering (NYSE: OII) from Market Perform to Outperform Canaccord downgrades Vermillion (NASDAQ: VRML) from Buy to Hold Wedbush downgrades Karyopharm Therapeutics (NASDAQ: KPTI) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

  • [By Max Byerly]

    First Trust Advisors LP grew its holdings in shares of Oceaneering International (NYSE:OII) by 172.4% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 812,975 shares of the oil and gas company’s stock after buying an additional 514,553 shares during the period. First Trust Advisors LP’s holdings in Oceaneering International were worth $20,698,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    Eagle Boston Investment Management Inc. raised its holdings in Oceaneering International (NYSE:OII) by 4.4% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 231,939 shares of the oil and gas company’s stock after purchasing an additional 9,733 shares during the quarter. Eagle Boston Investment Management Inc.’s holdings in Oceaneering International were worth $5,905,000 as of its most recent filing with the SEC.

Top 10 Blue Chip Stocks To Own For 2019: HD Supply Holdings, Inc.(HDS)

Advisors' Opinion:
  • [By Logan Wallace]

    Get a free copy of the Zacks research report on HD Supply (HDS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Andra AP fonden purchased a new position in shares of HD Supply Holdings Inc (NASDAQ:HDS) in the second quarter, according to its most recent disclosure with the SEC. The firm purchased 308,500 shares of the industrial products company’s stock, valued at approximately $13,232,000. HD Supply makes up 0.4% of Andra AP fonden’s investment portfolio, making the stock its 2nd largest position.

  • [By Max Byerly]

    Element Capital Management LLC acquired a new stake in HD Supply Holdings Inc (NASDAQ:HDS) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 25,666 shares of the industrial products company’s stock, valued at approximately $974,000.

  • [By Logan Wallace]

    Rhumbline Advisers cut its stake in HD Supply Holdings Inc (NASDAQ:HDS) by 7.4% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 181,854 shares of the industrial products company’s stock after selling 14,628 shares during the period. Rhumbline Advisers owned about 0.10% of HD Supply worth $7,800,000 as of its most recent SEC filing.

Top 10 Blue Chip Stocks To Own For 2019: Ideal Power Inc.(IPWR)

Advisors' Opinion:
  • [By Max Byerly]

    Headlines about Ideal Power (NASDAQ:IPWR) have been trending somewhat positive recently, according to Accern Sentiment. The research group scores the sentiment of press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Ideal Power earned a daily sentiment score of 0.09 on Accern’s scale. Accern also gave media headlines about the industrial products company an impact score of 46.8284728476176 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Ideal Power (IPWR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    News articles about Ideal Power (NASDAQ:IPWR) have trended somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Ideal Power earned a coverage optimism score of 0.12 on Accern’s scale. Accern also gave press coverage about the industrial products company an impact score of 47.3748047378114 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Top 10 Blue Chip Stocks To Own For 2019: Netlist, Inc.(NLST)

Advisors' Opinion:
  • [By Money Morning Staff Reports]

    After looking at last week's top performing penny stocks, we'll show you a small-cap stock with real growth potential that just popped up on our radar…

    Penny Stock Current Share Price Last Week's Gain New Age Beverage Corp. (NADAQ: NBEV) $3.94 286.79% India Globalization Capital Inc. (NYSE: IGC) $2.18 181.55% Ascent Capital Group Inc. (NASDAQ: ASCMA) $2.16 103.85% Netlist Inc. (NASDAQ: NLST) $0.73 80.56% Oragenics Inc. (NYSE: OGEN) $0.92 71.63% Astrotech Corp. (NASDAQ: ASTC) $3.44 68.37% Command Security Corp. (NYSE: MOC) $2.77 51.09% Oasmia Pharmaceuticals (NASDAQ: OASM) $3.57 50.66% NovaBay Pharmaceuticals Inc. (NYSE: NBY) $2.10 48.15% Navidea Biopharmaceuticals Inc. (NYSE: NAVB) $0.25 45.72%

    While the gains these stocks made are exciting, they also highlight the danger of investing in penny stocks.

  • [By Stephan Byrd]

    Netlist, Inc. (NASDAQ:NLST)’s share price traded down 6.3% during trading on Tuesday . The stock traded as low as $0.17 and last traded at $0.17. 2,960 shares changed hands during trading, a decline of 100% from the average session volume of 2,102,591 shares. The stock had previously closed at $0.16.

  • [By Money Morning News Team]

    On Sept. 11, Netlist Inc. (NASDAQ: NLST) gained 542% in the wake of news that the company had been victorious in a patent lawsuit.

    This ruling related to one of the company's most lucrative patents. While not conclusive, CEO C.K. Hong says that this latest development will allow a final decision by the U.S. International Trade Commission within the next several months.

  • [By Money Morning News Team]

    On Sept. 11, Netlist Inc. (NASDAQ: NLST) gained 542% in the wake of news that the company had been victorious in a patent lawsuit.

    This ruling related to one of the company's most lucrative patents. While not conclusive, CEO C.K. Hong says that this latest development will allow a final decision by the U.S. International Trade Commission within the next several months.

Top 10 Blue Chip Stocks To Own For 2019: Intrexon Corporation(XON)

Advisors' Opinion:
  • [By Keith Speights]

    Shares of Intrexon Corporation (NYSE:XON) were up 28.5% as of 11:19 a.m. on Monday. The biotech announced what it said were "advances in production of medical cannabis." In particular, Intrexon stated that its scientists had engineered a yeast strain that could be used in a microbial fermentation process to produce cannabinoids at low cost.

  • [By Todd Campbell]

    After the company reported disappointing first-quarter financial results, including worse-than-expected revenue performance, shares in Intrexon Corp. (NYSE:XON) were down by 20% at 3:15 p.m. EDT Friday.

  • [By Peter Graham]

    Small cap synthetic biology Intrexon Corp (NYSE: XON) has elevated short interest of 33.93% according to Highshortinterest.com. Intrexon Corp says its "powering the Bioindustrial Revolution with Better DNA™ to create biologically-based products that improve the quality of life and the health of the planet." The Company's integrated technology suite provides its partners across diverse markets with industrial-scale design and development of complex biological systems delivering unprecedented control, quality, function and performance of living cells. 

Top 10 Blue Chip Stocks To Own For 2019: Hudson Global, Inc.(HSON)

Advisors' Opinion:
  • [By Shane Hupp]

    JBF Capital Inc. purchased a new position in Hudson Global Inc (NASDAQ:HSON) in the second quarter, Holdings Channel reports. The fund purchased 157,917 shares of the business services provider’s stock, valued at approximately $256,000.

Top 10 Blue Chip Stocks To Own For 2019: Dynavax Technologies Corporation(DVAX)

Advisors' Opinion:
  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Dynavax Technologies (DVAX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By William Romov]

    If a biotech stock's clinical trial results are positive, or receives a nod of approval from the FDA, then the stock can soar. For example, last year Dynavax Technologies Corp. (Nasdaq: DVAX) shares more than quadrupled between May 31 and Oct. 5, when it climbed 337.6%, from $5.50 to $24.07.

  • [By Lisa Levin] Gainers ARMO BioSciences, Inc. (NASDAQ: ARMO) shares rose 67.5 percent to $49.96 in pre-market trading after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share. Turtle Beach Corporation (NASDAQ: HEAR) rose 62.8 percent to $11.30 in pre-market trading after the company reported Q1 results and raised its FY18 outlook. vTv Therapeutics Inc. (NASDAQ: VTVT) rose 23.4 percent to $2.11 in pre-market trading following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June. Resonant Inc. (NASDAQ: RESN) rose 19.1 percent to $5.00 in pre-market trading after reporting Q1 results. RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 17.7 percent to $2.39 in pre-market trading following Q1 results. Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 15.2 percent to $2.20 in pre-market trading after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million. Everspin Technologies, Inc. (NASDAQ: MRAM) rose 14.6 percent to $8.50 in pre-market trading after the company reported strong results for its first quarter. Carvana Co. (NYSE: CVNA) shares rose 11 percent to $27.50 in pre-market trading after reporting upbeat Q1 sales. Sunrun Inc. (NASDAQ: RUN) rose 8.9 percent to $10.70 in pre-market trading following upbeat quarterly earnings. MediciNova, Inc. (NASDAQ: MNOV) rose 8.1 percent to $11.35 in pre-market trading after the company announced opening of Investigational New Drug Application for MN-166 (ibudilast) in glioblastoma. New Gold Inc. (NYSE: NGD) shares rose 7.7 percent to $2.65 in pre-market trading after the company reported that its President and CEO Hannes Portmann left the company. The company named Raymond Threlkeld as successor. Otter Tail Corporation (NASDAQ: OTTR) shares rose 7.4 percent to $46.60 in the pre-market trading session. Himax Technologies, Inc. (NASDAQ: HIMX) shares rose
  • [By Lisa Levin] Gainers Turtle Beach Corporation (NASDAQ: HEAR) surged 87.1 percent to $12.98 after the company reported Q1 results and raised its FY18 outlook. ARMO BioSciences, Inc. (NASDAQ: ARMO) shares jumped 66.8 percent to $49.735 after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share. vTv Therapeutics Inc. (NASDAQ: VTVT) gained 34 percent to $2.2920 following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June. Prestige Brands Holdings, Inc. (NYSE: PBH) climbed 22.3 percent to $34.84 after the company posted upbeat Q4 earnings. Depomed, Inc. (NASDAQ: DEPO) shares jumped 22.2 percent to $7.28 following better-than-expected Q1 earnings. Everspin Technologies, Inc. (NASDAQ: MRAM) gained 19.8 percent to $8.89 after the company reported strong results for its first quarter. Luxfer Holdings PLC (NYSE: LXFR) surged 19.8 percent to $17.10 following Q1 results. Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 18.3 percent to $2.26 after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million. Intelligent Systems Corporation (NYSE: INS) gained 17 percent to $7.116. Green Dot Corporation (NYSE: GDOT) surged 15.3 percent to $73.00 after reporting upbeat Q1 earnings. The Chefs' Warehouse, Inc. (NASDAQ: CHEF) climbed 15 percent to $28.85. Chefs' Warehouse posted Q1 earnings of $0.03 per share on sales of $318.6 million. Westport Fuel Systems Inc. (NASDAQ: WPRT) rose 14.2 percent to $2.9701. Wright Medical Group N.V. (NASDAQ: WMGI) jumped 13.8 percent to $23.87 after reporting upbeat quarterly earnings. Diplomat Pharmacy, Inc. (NYSE: DPLO) gained 13.4 percent to $22.70. Diplomat named Brian Griffin as Chairman and CEO. Carvana Co. (NYSE: CVNA) shares rose 13 percent to $27.97 after reporting upbeat Q1 sales. Prothena Corporation plc (NASDAQ: PRTA) gained 12 percent to $15.19
  • [By George Budwell]

    Over the past few years, however, several beaten-down biotech stocks have ended up producing enormous gains for risk-tolerant investors. For example, Acadia Pharmaceuticals (NASDAQ:ACAD), Exelixis (NASDAQ:EXEL), and Dynavax Technologies Corporation (NASDAQ:DVAX) were all once so-called "penny stocks" that went on to rebound nicely once their lead clinical candidates made it successfully onto the market.

  • [By Cooper Creagan]

    The same is true for Dynavax Technologies Corp. (Nasdaq: DVAX). A quick Night Trade of DVAX would've netted a whopping 230% in just a few months – and this can all be done from the comfort of your own home.

No comments:

Post a Comment